Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen*, Nicole C. T. van Grieken, Karolina Sikorska, Pehr Lind, Marianne Nordsmark, Elma Meershoek-Klein Kranenbarg, Henk Boot, Anouk K. Trip, H. A. Maurits Swellengrebel, Hanneke W. M. van Laarhoven, Hein Putter, Johanna W. van Sandick, Mark I. van Berge Henegouwen, Henk H. Hartgrink, Harm van Tinteren, Cornelis J. H. van de Velde, Marcel Verheij, CRITICS Investigators, Robertus Jansen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)616-628
Number of pages13
JournalLancet oncology
Volume19
Issue number5
DOIs
Publication statusPublished - May 2018

Keywords

  • PERIOPERATIVE CHEMOTHERAPY
  • III TRIAL
  • POSTOPERATIVE CHEMORADIOTHERAPY
  • GASTROESOPHAGEAL JUNCTION
  • CAPECITABINE CHEMOTHERAPY
  • NODAL DISSECTION
  • DOSE-ESCALATION
  • I-II
  • ADENOCARCINOMA
  • CISPLATIN

Cite this